Open AccessTHE EFFICACY OF THE COSTS ON SEVERE RESPIRATORY SYNCYTIAL INFECTION PREVENTION WITH PALIVIZUMAB IN PRETERM INFANTS
Author(s) -
А. В. Рудакова,
И. В. Бабаченко,
В. Б. Ровный,
А. Н. Усков,
Ю. В. Лобзин
Publication year - 2012
Publication title -
voprosy sovremennoj pediatrii
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.12
H-Index - 5
eISSN - 1682-5535
pISSN - 1682-5527
DOI - 10.15690/vsp.v11i4.374
Subject(s) - palivizumab , medicine , pediatrics , indirect costs , gestation , randomized controlled trial , population , etiology , intensive care medicine , respiratory system , environmental health , pregnancy , accounting , biology , business , genetics